Cargando…

Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy

Esophageal cancer (EC) has a high incidence and poor prognosis. The two major histological types, squamous cell carcinoma and adenocarcinoma, differ in their epidemiology and treatment options. Patients with locally advanced EC benefit from multimodal therapy concepts including neoadjuvant chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yan, Feng, Xijia, Li, Chengqiang, Lerut, Toni, Li, Hecheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771193/ https://www.ncbi.nlm.nih.gov/pubmed/36525602 http://dx.doi.org/10.1097/CM9.0000000000002371

Ejemplares similares

Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study
por: Li, Chengqiang, et al.
Publicado: (2023)

Corrigendum: treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy
Publicado: (2023)

Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer
por: Jian, Zheng, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients
por: Zhang, Qiurui, et al.
Publicado: (2023)

Robotic versus thoracoscopic combined anatomic subsegmentectomy for early-stage lung cancer: early results of a cohort study
por: Jian, Zheng, et al.
Publicado: (2022)

Robotic sleeve resection for pulmonary disease
por: Li, Chengqiang, et al.
Publicado: (2018)

Neoadjuvant immunotherapy for resectable esophageal cancer: A review
por: Li, Qing, et al.
Publicado: (2022)

Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
por: Wang, Hesong, et al.
Publicado: (2023)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design
por: Zheng, Yuyan, et al.
Publicado: (2021)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

The diverse role of RNA methylation in esophageal cancer: RNA methylation in esophageal cancer
por: Meng, Wangyang, et al.
Publicado: (2023)

Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy
por: Depypere, Lieven, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis
por: Yu, Guocan, et al.
Publicado: (2021)

Intraoperative Identification of the Intersegmental Plane: From the Beginning to the Future
por: Zhang, Xianfei, et al.
Publicado: (2022)

Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
por: Ameye, Heleen, et al.
Publicado: (2016)

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort
por: Qi, Wei‐Xiang, et al.
Publicado: (2023)

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
por: Dai, Huiru, et al.
Publicado: (2022)

Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review
por: Cao, Luchang, et al.
Publicado: (2021)

Augmented reality navigation-guided pulmonary nodule localization in a canine model
por: Li, Chengqiang, et al.
Publicado: (2021)

Role of ferroptosis in esophageal cancer and corresponding immunotherapy
por: Fan, Xin, et al.
Publicado: (2023)

History of esophagectomy for cancer of the esophagus and the gastroesophageal junction
por: Lerut, Toni, et al.
Publicado: (2021)

Adjuvant Immunotherapy in Curative Intent Esophageal Cancer Resection Patients: Real-World Experience within an Integrated Health System
por: Kwak, Hyunjee V., et al.
Publicado: (2023)

Robot-assisted Ivor Lewis Esophagectomy (RAILE): A review of surgical techniques and clinical outcomes
por: Shen, Tianzheng, et al.
Publicado: (2022)

Biomarkers for immunotherapy in esophageal cancer
por: Wang, Xuelian, et al.
Publicado: (2023)

Responses to commentary on ‘Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: a systematic review and meta-analysis’ (Int J Surg 2022;106:106929)
por: Wang, Zhaoyang, et al.
Publicado: (2023)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
por: Zhou, Qing, et al.
Publicado: (2023)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab
por: Yu, Lan, et al.
Publicado: (2021)

Commentary: Eliminating cervical anastomotic leak after esophagectomy: To supercharge or not to supercharge, that's the question
por: Lerut, Toni
Publicado: (2020)

Natural Products for Esophageal Cancer Therapy: From Traditional Medicine to Modern Drug Discovery
por: An, Jeongeun, et al.
Publicado: (2022)

Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review
por: Zhu, Jie, et al.
Publicado: (2022)

Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Development and validation of an autophagy-related prognostic signature in esophageal cancer
por: Du, Hailei, et al.
Publicado: (2021)

Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer
por: Fan, Mengying, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials
por: Zhu, Jie, et al.
Publicado: (2022)

Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy
por: Matsui, Hiroto, et al.
Publicado: (2017)

Endoscopic resection of superficial esophageal cancer covered with esophageal varices
por: Heo, Dae-Hyuk, et al.
Publicado: (2022)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5cj7o2cmlqj2if7cb36fij5jh1